Tell us about your search experience on the TGA website - complete our short survey
Sponsor content
24 result(s) found, displaying 1 to 10
- Australian Public Assessment Report (AusPAR)AusPAR: NuvaxovidNuvaxovid (SARS-CoV-2 rS with Matrix M adjuvant (NVX-CoV2373)) for prevention of COVID-19 in individuals 12 years of age and older.
- Prescription medicine registrationNUVAXOVID-SARS-CoV-2 rS (NVX-CoV2373) (Biocelect Pty Ltd)Active ingredients: SARS-CoV-2 rS (NVX-CoV2373).
- COVID-19 test kitSTANDARD™ Q COVID-19 Ag Test Nasal SwabAntigen Test - Intended for use: Point-of-care
- Jul-2022Prescription medicine evaluationVAXCHORA Biocelect Pty LtdActive ingredient: Vibrio cholerae.
- Australian Public Assessment Report (AusPAR)AusPAR: Nuvaxovid homologous boosterNuvaxovid homologous booster (CoV-2 rS with Matrix M adjuvant (NVX-CoV2373)) for the prevention of COVID-19.
- Australian Public Assessment Report (AusPAR)AusPAR: Nuvaxovid heterologous boosterNuvaxovid heterologous booster (CoV-2 rS with Matrix M adjuvant (NVX-CoV2373)) for the prevention of COVID-19.
- Designation or determinationNotice for SARS-CoV-2-rS (NVX-CoV2373) (Biocelect Pty Ltd)Provisional determination
- Australian Public Assessment Report (AusPAR)AusPAR: SARS-CoV-2 rS with Matrix-M adjuvantAustralian Public Assessment Report for SARS-CoV-2 rS with Matrix-M adjuvant
- ARTGNUVAXOVID (SARS-CoV-2 rS [NVX-CoV2373]) COVID-19 VACCINE adjuvanted suspension for injection vial (355139)Australian Register of Therapeutic Goods (ARTG) information for NUVAXOVID (SARS-CoV-2 rS [NVX-CoV2373]) COVID-19 VACCINE adjuvanted suspension for injection vial.